CYTARABINE ACCORD cytarabine 1000 mg/10 mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cytarabine accord cytarabine 1000 mg/10 ml injection vial

accord healthcare pty ltd - cytarabine, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections; macrogol 400; trometamol - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

CYTARABINE ACC cytarabine 40 mg/2 mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cytarabine acc cytarabine 40 mg/2 ml injection vial

accord healthcare pty ltd - cytarabine, quantity: 40 mg - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

CYTARABINE ACCORD cytarabine 500 mg/5 mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cytarabine accord cytarabine 500 mg/5 ml injection vial

accord healthcare pty ltd - cytarabine, quantity: 500 mg - injection, solution - excipient ingredients: water for injections; macrogol 400; trometamol - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

CYTARABINE ACCORD cytarabine 100 mg/1 mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cytarabine accord cytarabine 100 mg/1 ml injection vial

accord healthcare pty ltd - cytarabine, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; macrogol 400; trometamol - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

CYTARABINE ACCORD cytarabine 2000 mg/20 mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cytarabine accord cytarabine 2000 mg/20 ml injection vial

accord healthcare pty ltd - cytarabine, quantity: 2000 mg - injection, solution - excipient ingredients: water for injections; macrogol 400; trometamol - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

CYTARABINE ACCORD cytarabine 4000 mg/40 mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cytarabine accord cytarabine 4000 mg/40 ml injection vial

accord healthcare pty ltd - cytarabine, quantity: 4000 mg - injection, solution - excipient ingredients: water for injections; macrogol 400; trometamol - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

Cytosar 100 mg/5 ml inj. sol. i.thec./s.c./i.v. vial Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cytosar 100 mg/5 ml inj. sol. i.thec./s.c./i.v. vial

pfizer sa-nv - cytarabine 100 mg/5 ml - solution for injection - 20 mg/ml - cytarabine 100 mg - cytarabine

Alexan Solution For Injection 100 mg/5ml Jordaania - inglise - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

alexan solution for injection 100 mg/5ml

مستودع ادوية الصباغ - sabbagh drug store - cytarabine 100 mg/5ml - 100 mg/5ml

Cytarabine 100mg/ml solution for injection or infusion (5ml) Malta - inglise - Medicines Authority

cytarabine 100mg/ml solution for injection or infusion (5ml)

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - cytarabine - solution for infusion or injection - cytarabine 100 mg/ml - antineoplastic agents

Cytarabine 100mg/ml solution for injection or infusion (10ml) Malta - inglise - Medicines Authority

cytarabine 100mg/ml solution for injection or infusion (10ml)

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - cytarabine - solution for infusion or injection - cytarabine 100 mg/ml - antineoplastic agents